NCT00516724 2025-04-11Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelAstraZenecaPhase 1 Completed189 enrolled
NCT02358200 2020-01-10Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast CancerUniversity of California, San FranciscoPhase 1 Terminated23 enrolled